Effect of hexachlorophane on incidence of staphylococcal and gram-negative infection in the newborn.
D003428:Cross Infection / Q000382:microbiology / Q000517:prevention & control*; D004352:Drug Resistance, Microbial; D004926:Escherichia coli / Q000302:isolation & purification; D004927:Escherichia coli Infections / Q000453:epidemiology; D006190:Haemophilus / Q000302:isolation & purification; D006582:Hexachlorophene; D006801:Humans; D007224:Infant Care; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000453:epidemiology*; D011512:Proteus Infections / Q000453:epidemiology; D011552:Pseudomonas Infections / Q000453:epidemiology; D011550:Pseudomonas aeruginosa / Q000302:isolation & purification; D012606:Scotland; D013203:Staphylococcal Infections / Q000517:prevention & control*; D013210:Staphylococcus / Q000302:isolation & purification
D006582:Hexachlorophene